Travere Therapeutics, Inc. ($TVTX)
Baynes Roy D. โ Director
Shares
9,750
Price
$0.00
Total Value
$0.00
Nearby Earnings
Apr 29, 2026
Transaction Details
| Insider | Baynes Roy D. |
|---|---|
| Title | Director |
| Transaction Date | May 1, 2026 |
| Expiration Date | May 8, 2034 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | May 4, 2026 |
| Shares Purchased | 9,750 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 9,750 |
| Derivative | Derivative |
| Accession Number | 0001680739-26-000007 |
| Document | View SEC Filing |